> top > docs > PubMed:10362835 > annotations

PubMed:10362835 JSONTXT

Annnotations TAB JSON ListView MergeView

Glycan-Motif

Id Subject Object Predicate Lexical cue
T1 98-117 https://glytoucan.org/Structures/Glycans/G00055MO denotes N-acetyllactosamine
T2 698-717 https://glytoucan.org/Structures/Glycans/G64581RP denotes N-acetylglucosamine
T3 794-803 https://glytoucan.org/Structures/Glycans/G65889KE denotes galactose
T4 794-803 https://glytoucan.org/Structures/Glycans/G68158BT denotes galactose

GlyCosmos6-Glycan-Motif-Image

Id Subject Object Predicate Lexical cue image
T1 98-117 Glycan_Motif denotes N-acetyllactosamine https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00055MO
T2 698-717 Glycan_Motif denotes N-acetylglucosamine https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G64581RP
T3 794-803 Glycan_Motif denotes galactose https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G68158BT|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G65889KE

GlyCosmos6-Glycan-Motif-Structure

Id Subject Object Predicate Lexical cue
T1 98-117 https://glytoucan.org/Structures/Glycans/G00055MO denotes N-acetyllactosamine
T2 698-717 https://glytoucan.org/Structures/Glycans/G64581RP denotes N-acetylglucosamine
T3 794-803 https://glytoucan.org/Structures/Glycans/G65889KE denotes galactose
T4 794-803 https://glytoucan.org/Structures/Glycans/G68158BT denotes galactose

sentences

Id Subject Object Predicate Lexical cue
TextSentencer_T1 0-132 Sentence denotes Characterization of the substrate specificity of alpha1,3galactosyltransferase utilizing modified N-acetyllactosamine disaccharides.
TextSentencer_T2 133-342 Sentence denotes alpha1,3galactosyltransferase (alpha1,3GalT) catalyzes the synthesis of a range of glycoconjugates containing the Galalpha1,3Gal epitope which is recognized by the naturally occurring human antibody, anti-Gal.
TextSentencer_T3 343-524 Sentence denotes This enzyme may be a useful synthetic tool to produce a range of compounds to further investigate the binding site of anti-Gal and other proteins with a Galalpha1,3Gal binding site.
TextSentencer_T4 525-627 Sentence denotes Thus, the enzyme has been probed with a series of type 2 disaccharide-C8(Galbeta1-4GlcNAc-C8) analogs.
TextSentencer_T5 628-804 Sentence denotes The enzyme tolerated acceptors with modifications at C2 and C3 of the N-acetylglucosamine residue, producing a family of compounds with a nonreducing alpha1,3 linked galactose.
TextSentencer_T6 805-876 Sentence denotes Compounds that did not serve as acceptors were evaluated as inhibitors.
TextSentencer_T7 877-1038 Sentence denotes Interestingly, the type 1 disaccharide-C8, Galbeta1-3GlcNAc-C8, was a good inhibitor of the enzyme (Ki = 270 microM vs. Km = 190 microM for Galbeta1-4GlcNAc-C8).
TextSentencer_T8 1039-1431 Sentence denotes A potential photoprobe, based on a modified type 2 disaccharide (octyl 3-amino-3-deoxy-3-N-(2-diazo-3, 3, 3-trifluoropropionyl-beta-D-galactopyranosyl-(1, 4)-2-acetamindo-2-deoxy-beta-D-glycopyranoside, (DTFP-LacNAc-C8)), was evaluated as an inhibitor of alpha1,3GalT. alpha1,3GalT bound DTFP-LacNAc-C8 with an affinity (Ki = 300 microM) similar to that displayed by the enzyme for LacNAc-C8.
TextSentencer_T9 1432-1547 Sentence denotes Additional studies were done to determine the enzyme's ability to transfer a range of sugars from UDP-sugar donors.
TextSentencer_T10 1548-1649 Sentence denotes The results of these experiments demonstrated that alpha1,3GalT has a strict specificity for UDP-Gal.
TextSentencer_T11 1650-1824 Sentence denotes Finally, inactivation studies with various amino acid modifiers were done to obtain information on the importance of different types of amino acids for alpha1,3GalT activity.
T1 0-132 Sentence denotes Characterization of the substrate specificity of alpha1,3galactosyltransferase utilizing modified N-acetyllactosamine disaccharides.
T2 133-524 Sentence denotes alpha1,3galactosyltransferase (alpha1,3GalT) catalyzes the synthesis of a range of glycoconjugates containing the Galalpha1,3Gal epitope which is recognized by the naturally occurring human antibody, anti-Gal. This enzyme may be a useful synthetic tool to produce a range of compounds to further investigate the binding site of anti-Gal and other proteins with a Galalpha1,3Gal binding site.
T3 525-627 Sentence denotes Thus, the enzyme has been probed with a series of type 2 disaccharide-C8(Galbeta1-4GlcNAc-C8) analogs.
T4 628-804 Sentence denotes The enzyme tolerated acceptors with modifications at C2 and C3 of the N-acetylglucosamine residue, producing a family of compounds with a nonreducing alpha1,3 linked galactose.
T5 805-876 Sentence denotes Compounds that did not serve as acceptors were evaluated as inhibitors.
T6 877-1038 Sentence denotes Interestingly, the type 1 disaccharide-C8, Galbeta1-3GlcNAc-C8, was a good inhibitor of the enzyme (Ki = 270 microM vs. Km = 190 microM for Galbeta1-4GlcNAc-C8).
T7 1039-1431 Sentence denotes A potential photoprobe, based on a modified type 2 disaccharide (octyl 3-amino-3-deoxy-3-N-(2-diazo-3, 3, 3-trifluoropropionyl-beta-D-galactopyranosyl-(1, 4)-2-acetamindo-2-deoxy-beta-D-glycopyranoside, (DTFP-LacNAc-C8)), was evaluated as an inhibitor of alpha1,3GalT. alpha1,3GalT bound DTFP-LacNAc-C8 with an affinity (Ki = 300 microM) similar to that displayed by the enzyme for LacNAc-C8.
T8 1432-1547 Sentence denotes Additional studies were done to determine the enzyme's ability to transfer a range of sugars from UDP-sugar donors.
T9 1548-1824 Sentence denotes The results of these experiments demonstrated that alpha1,3GalT has a strict specificity for UDP-Gal. Finally, inactivation studies with various amino acid modifiers were done to obtain information on the importance of different types of amino acids for alpha1,3GalT activity.
T1 0-132 Sentence denotes Characterization of the substrate specificity of alpha1,3galactosyltransferase utilizing modified N-acetyllactosamine disaccharides.
T2 133-342 Sentence denotes alpha1,3galactosyltransferase (alpha1,3GalT) catalyzes the synthesis of a range of glycoconjugates containing the Galalpha1,3Gal epitope which is recognized by the naturally occurring human antibody, anti-Gal.
T3 343-524 Sentence denotes This enzyme may be a useful synthetic tool to produce a range of compounds to further investigate the binding site of anti-Gal and other proteins with a Galalpha1,3Gal binding site.
T4 525-627 Sentence denotes Thus, the enzyme has been probed with a series of type 2 disaccharide-C8(Galbeta1-4GlcNAc-C8) analogs.
T5 628-804 Sentence denotes The enzyme tolerated acceptors with modifications at C2 and C3 of the N-acetylglucosamine residue, producing a family of compounds with a nonreducing alpha1,3 linked galactose.
T6 805-876 Sentence denotes Compounds that did not serve as acceptors were evaluated as inhibitors.
T7 877-1038 Sentence denotes Interestingly, the type 1 disaccharide-C8, Galbeta1-3GlcNAc-C8, was a good inhibitor of the enzyme (Ki = 270 microM vs. Km = 190 microM for Galbeta1-4GlcNAc-C8).
T8 1039-1431 Sentence denotes A potential photoprobe, based on a modified type 2 disaccharide (octyl 3-amino-3-deoxy-3-N-(2-diazo-3, 3, 3-trifluoropropionyl-beta-D-galactopyranosyl-(1, 4)-2-acetamindo-2-deoxy-beta-D-glycopyranoside, (DTFP-LacNAc-C8)), was evaluated as an inhibitor of alpha1,3GalT. alpha1,3GalT bound DTFP-LacNAc-C8 with an affinity (Ki = 300 microM) similar to that displayed by the enzyme for LacNAc-C8.
T9 1432-1547 Sentence denotes Additional studies were done to determine the enzyme's ability to transfer a range of sugars from UDP-sugar donors.
T10 1548-1649 Sentence denotes The results of these experiments demonstrated that alpha1,3GalT has a strict specificity for UDP-Gal.
T11 1650-1824 Sentence denotes Finally, inactivation studies with various amino acid modifiers were done to obtain information on the importance of different types of amino acids for alpha1,3GalT activity.

GlycoBiology-FMA

Id Subject Object Predicate Lexical cue
_T2 98-117 FMAID:82786 denotes N-acetyllactosamine
_T1 98-117 FMAID:196780 denotes N-acetyllactosamine
_T3 118-131 FMAID:82744 denotes disaccharides
_T4 118-131 FMAID:196733 denotes disaccharides
_T5 216-231 FMAID:82782 denotes glycoconjugates
_T6 216-231 FMAID:196776 denotes glycoconjugates
_T7 323-331 FMAID:167180 denotes antibody
_T8 408-417 FMAID:165656 denotes compounds
_T9 408-417 FMAID:67745 denotes compounds
_T10 480-488 FMAID:67257 denotes proteins
_T11 480-488 FMAID:165447 denotes proteins
_T12 582-594 FMAID:82744 denotes disaccharide
_T13 582-594 FMAID:196733 denotes disaccharide
_T14 595-597 FMAID:167726 denotes C8
_T15 595-597 FMAID:63501 denotes C8
_T16 615-617 FMAID:167726 denotes C8
_T17 615-617 FMAID:63501 denotes C8
_T18 681-683 FMAID:63494 denotes C2
_T19 681-683 FMAID:167719 denotes C2
_T20 688-690 FMAID:167721 denotes C3
_T21 688-690 FMAID:63496 denotes C3
_T22 698-717 FMAID:82787 denotes N-acetylglucosamine
_T23 698-717 FMAID:196781 denotes N-acetylglucosamine
_T24 749-758 FMAID:67745 denotes compounds
_T25 749-758 FMAID:165656 denotes compounds
_T26 794-803 FMAID:196789 denotes galactose
_T27 794-803 FMAID:82794 denotes galactose
_T28 805-814 FMAID:165656 denotes Compounds
_T29 805-814 FMAID:67745 denotes Compounds
_T30 903-915 FMAID:82744 denotes disaccharide
_T31 903-915 FMAID:196733 denotes disaccharide
_T32 916-918 FMAID:63501 denotes C8
_T33 916-918 FMAID:167726 denotes C8
_T34 937-939 FMAID:63501 denotes C8
_T35 937-939 FMAID:167726 denotes C8
_T36 986-992 FMAID:165145 denotes microM
_T37 1006-1012 FMAID:165145 denotes microM
_T38 1034-1036 FMAID:167726 denotes C8
_T39 1034-1036 FMAID:63501 denotes C8
_T40 1090-1102 FMAID:82744 denotes disaccharide
_T41 1090-1102 FMAID:196733 denotes disaccharide
_T42 1255-1257 FMAID:167726 denotes C8
_T43 1255-1257 FMAID:63501 denotes C8
_T44 1339-1341 FMAID:63501 denotes C8
_T45 1339-1341 FMAID:167726 denotes C8
_T46 1369-1375 FMAID:165145 denotes microM
_T47 1428-1430 FMAID:167726 denotes C8
_T48 1428-1430 FMAID:63501 denotes C8
_T49 1498-1508 FMAID:165205 denotes transfer a
_T50 1518-1524 FMAID:196724 denotes sugars
_T51 1534-1539 FMAID:196724 denotes sugar
_T52 1693-1703 FMAID:82739 denotes amino acid
_T53 1693-1703 FMAID:196728 denotes amino acid
_T54 1786-1797 FMAID:196728 denotes amino acids
_T55 1786-1797 FMAID:82739 denotes amino acids

uniprot-human

Id Subject Object Predicate Lexical cue
T1 595-597 http://www.uniprot.org/uniprot/Q99618 denotes C8
T2 615-617 http://www.uniprot.org/uniprot/Q99618 denotes C8
T3 916-918 http://www.uniprot.org/uniprot/Q99618 denotes C8
T4 937-939 http://www.uniprot.org/uniprot/Q99618 denotes C8
T5 1034-1036 http://www.uniprot.org/uniprot/Q99618 denotes C8
T6 1255-1257 http://www.uniprot.org/uniprot/Q99618 denotes C8
T7 1339-1341 http://www.uniprot.org/uniprot/Q99618 denotes C8
T8 1428-1430 http://www.uniprot.org/uniprot/Q99618 denotes C8
T9 681-683 http://www.uniprot.org/uniprot/P06681 denotes C2
T10 688-690 http://www.uniprot.org/uniprot/P01024 denotes C3

uniprot-mouse

Id Subject Object Predicate Lexical cue
T1 595-597 http://www.uniprot.org/uniprot/Q99M54 denotes C8
T2 615-617 http://www.uniprot.org/uniprot/Q99M54 denotes C8
T3 916-918 http://www.uniprot.org/uniprot/Q99M54 denotes C8
T4 937-939 http://www.uniprot.org/uniprot/Q99M54 denotes C8
T5 1034-1036 http://www.uniprot.org/uniprot/Q99M54 denotes C8
T6 1255-1257 http://www.uniprot.org/uniprot/Q99M54 denotes C8
T7 1339-1341 http://www.uniprot.org/uniprot/Q99M54 denotes C8
T8 1428-1430 http://www.uniprot.org/uniprot/Q99M54 denotes C8
T9 681-683 http://www.uniprot.org/uniprot/P21180 denotes C2
T10 688-690 http://www.uniprot.org/uniprot/P01027 denotes C3

GlycoBiology-NCBITAXON

Id Subject Object Predicate Lexical cue
T1 1166-1170 http://purl.bioontology.org/ontology/NCBITAXON/3554 denotes beta
T2 1166-1170 http://purl.bioontology.org/ontology/NCBITAXON/158455 denotes beta
T3 1218-1222 http://purl.bioontology.org/ontology/NCBITAXON/3554 denotes beta
T4 1218-1222 http://purl.bioontology.org/ontology/NCBITAXON/158455 denotes beta

GO-BP

Id Subject Object Predicate Lexical cue
T1 192-201 http://purl.obolibrary.org/obo/GO_0009058 denotes synthesis
T2 1693-1713 http://purl.obolibrary.org/obo/GO_0042219 denotes amino acid modifiers
T3 1693-1713 http://purl.obolibrary.org/obo/GO_0006575 denotes amino acid modifiers
T4 1693-1713 http://purl.obolibrary.org/obo/GO_0072337 denotes amino acid modifiers

GO-MF

Id Subject Object Predicate Lexical cue
T1 323-331 http://purl.obolibrary.org/obo/GO_0003823 denotes antibody
T2 445-452 http://purl.obolibrary.org/obo/GO_0070026 denotes binding
T3 511-518 http://purl.obolibrary.org/obo/GO_0070026 denotes binding
T4 445-452 http://purl.obolibrary.org/obo/GO_0003680 denotes binding
T5 511-518 http://purl.obolibrary.org/obo/GO_0003680 denotes binding
T6 445-452 http://purl.obolibrary.org/obo/GO_0017091 denotes binding
T7 511-518 http://purl.obolibrary.org/obo/GO_0017091 denotes binding
T8 445-452 http://purl.obolibrary.org/obo/GO_0005488 denotes binding
T9 511-518 http://purl.obolibrary.org/obo/GO_0005488 denotes binding
T10 1693-1713 http://purl.obolibrary.org/obo/GO_0072341 denotes amino acid modifiers

GO-CC

Id Subject Object Predicate Lexical cue
T1 993-995 http://purl.obolibrary.org/obo/GO_0039720 denotes vs

EDAM-topics

Id Subject Object Predicate Lexical cue
T1 317-322 http://edamontology.org/topic_2815 denotes human
T2 480-488 http://edamontology.org/topic_0078 denotes proteins
T3 551-557 http://edamontology.org/topic_0632 denotes probed
T4 1443-1450 http://edamontology.org/topic_3678 denotes studies
T5 1672-1679 http://edamontology.org/topic_3678 denotes studies
T6 1693-1703 http://edamontology.org/topic_0154 denotes amino acid
T7 1786-1797 http://edamontology.org/topic_0154 denotes amino acids

EDAM-DFO

Id Subject Object Predicate Lexical cue
T1 381-385 http://edamontology.org/data_0007 denotes tool
T2 480-488 http://edamontology.org/data_1467 denotes proteins
T3 480-488 http://edamontology.org/format_1208 denotes proteins
T4 718-725 http://edamontology.org/data_1756 denotes residue
T5 997-999 http://edamontology.org/data_0910 denotes Km
T6 1581-1593 http://edamontology.org/operation_2246 denotes demonstrated
T7 1777-1782 http://edamontology.org/data_2100 denotes types

GlyTouCan-IUPAC

Id Subject Object Predicate Lexical cue
GlycanIUPAC_T1 338-341 "http://rdf.glycoinfo.org/glycan/G93924TT" denotes Gal
GlycanIUPAC_T2 466-469 "http://rdf.glycoinfo.org/glycan/G93924TT" denotes Gal
GlycanIUPAC_T3 1645-1648 "http://rdf.glycoinfo.org/glycan/G93924TT" denotes Gal
GlycanIUPAC_T4 338-341 "http://rdf.glycoinfo.org/glycan/G25565DN" denotes Gal
GlycanIUPAC_T5 466-469 "http://rdf.glycoinfo.org/glycan/G25565DN" denotes Gal
GlycanIUPAC_T6 1645-1648 "http://rdf.glycoinfo.org/glycan/G25565DN" denotes Gal
GlycanIUPAC_T7 338-341 "http://rdf.glycoinfo.org/glycan/G97215EV" denotes Gal
GlycanIUPAC_T8 466-469 "http://rdf.glycoinfo.org/glycan/G97215EV" denotes Gal
GlycanIUPAC_T9 1645-1648 "http://rdf.glycoinfo.org/glycan/G97215EV" denotes Gal
GlycanIUPAC_T10 338-341 "http://rdf.glycoinfo.org/glycan/G79664KO" denotes Gal
GlycanIUPAC_T11 466-469 "http://rdf.glycoinfo.org/glycan/G79664KO" denotes Gal
GlycanIUPAC_T12 1645-1648 "http://rdf.glycoinfo.org/glycan/G79664KO" denotes Gal
GlycanIUPAC_T13 338-341 "http://rdf.glycoinfo.org/glycan/G24107FU" denotes Gal
GlycanIUPAC_T14 466-469 "http://rdf.glycoinfo.org/glycan/G24107FU" denotes Gal
GlycanIUPAC_T15 1645-1648 "http://rdf.glycoinfo.org/glycan/G24107FU" denotes Gal
GlycanIUPAC_T16 338-341 "http://rdf.glycoinfo.org/glycan/G09864UE" denotes Gal
GlycanIUPAC_T17 466-469 "http://rdf.glycoinfo.org/glycan/G09864UE" denotes Gal
GlycanIUPAC_T18 1645-1648 "http://rdf.glycoinfo.org/glycan/G09864UE" denotes Gal
GlycanIUPAC_T19 338-341 "http://rdf.glycoinfo.org/glycan/G28032MC" denotes Gal
GlycanIUPAC_T20 466-469 "http://rdf.glycoinfo.org/glycan/G28032MC" denotes Gal
GlycanIUPAC_T21 1645-1648 "http://rdf.glycoinfo.org/glycan/G28032MC" denotes Gal
GlycanIUPAC_T22 338-341 "http://rdf.glycoinfo.org/glycan/G28005UP" denotes Gal
GlycanIUPAC_T23 466-469 "http://rdf.glycoinfo.org/glycan/G28005UP" denotes Gal
GlycanIUPAC_T24 1645-1648 "http://rdf.glycoinfo.org/glycan/G28005UP" denotes Gal
GlycanIUPAC_T25 338-341 "http://rdf.glycoinfo.org/glycan/G92708AT" denotes Gal
GlycanIUPAC_T26 466-469 "http://rdf.glycoinfo.org/glycan/G92708AT" denotes Gal
GlycanIUPAC_T27 1645-1648 "http://rdf.glycoinfo.org/glycan/G92708AT" denotes Gal
GlycanIUPAC_T28 338-341 "http://rdf.glycoinfo.org/glycan/G73757UC" denotes Gal
GlycanIUPAC_T29 466-469 "http://rdf.glycoinfo.org/glycan/G73757UC" denotes Gal
GlycanIUPAC_T30 1645-1648 "http://rdf.glycoinfo.org/glycan/G73757UC" denotes Gal
GlycanIUPAC_T31 338-341 "http://rdf.glycoinfo.org/glycan/G51062DM" denotes Gal
GlycanIUPAC_T32 466-469 "http://rdf.glycoinfo.org/glycan/G51062DM" denotes Gal
GlycanIUPAC_T33 1645-1648 "http://rdf.glycoinfo.org/glycan/G51062DM" denotes Gal
GlycanIUPAC_T34 338-341 "http://rdf.glycoinfo.org/glycan/G05866BJ" denotes Gal
GlycanIUPAC_T35 466-469 "http://rdf.glycoinfo.org/glycan/G05866BJ" denotes Gal
GlycanIUPAC_T36 1645-1648 "http://rdf.glycoinfo.org/glycan/G05866BJ" denotes Gal
GlycanIUPAC_T37 338-341 "http://rdf.glycoinfo.org/glycan/G87394FZ" denotes Gal
GlycanIUPAC_T38 466-469 "http://rdf.glycoinfo.org/glycan/G87394FZ" denotes Gal
GlycanIUPAC_T39 1645-1648 "http://rdf.glycoinfo.org/glycan/G87394FZ" denotes Gal
GlycanIUPAC_T40 338-341 "http://rdf.glycoinfo.org/glycan/G03871NF" denotes Gal
GlycanIUPAC_T41 466-469 "http://rdf.glycoinfo.org/glycan/G03871NF" denotes Gal
GlycanIUPAC_T42 1645-1648 "http://rdf.glycoinfo.org/glycan/G03871NF" denotes Gal
GlycanIUPAC_T43 338-341 "http://rdf.glycoinfo.org/glycan/G29377VE" denotes Gal
GlycanIUPAC_T44 466-469 "http://rdf.glycoinfo.org/glycan/G29377VE" denotes Gal
GlycanIUPAC_T45 1645-1648 "http://rdf.glycoinfo.org/glycan/G29377VE" denotes Gal
GlycanIUPAC_T46 338-341 "http://rdf.glycoinfo.org/glycan/G33457CX" denotes Gal
GlycanIUPAC_T47 466-469 "http://rdf.glycoinfo.org/glycan/G33457CX" denotes Gal
GlycanIUPAC_T48 1645-1648 "http://rdf.glycoinfo.org/glycan/G33457CX" denotes Gal
GlycanIUPAC_T49 338-341 "http://rdf.glycoinfo.org/glycan/G97368GU" denotes Gal
GlycanIUPAC_T50 466-469 "http://rdf.glycoinfo.org/glycan/G97368GU" denotes Gal
GlycanIUPAC_T51 1645-1648 "http://rdf.glycoinfo.org/glycan/G97368GU" denotes Gal
GlycanIUPAC_T52 338-341 "http://rdf.glycoinfo.org/glycan/G18512EL" denotes Gal
GlycanIUPAC_T53 466-469 "http://rdf.glycoinfo.org/glycan/G18512EL" denotes Gal
GlycanIUPAC_T54 1645-1648 "http://rdf.glycoinfo.org/glycan/G18512EL" denotes Gal
GlycanIUPAC_T55 338-341 "http://rdf.glycoinfo.org/glycan/G41137VS" denotes Gal
GlycanIUPAC_T56 466-469 "http://rdf.glycoinfo.org/glycan/G41137VS" denotes Gal
GlycanIUPAC_T57 1645-1648 "http://rdf.glycoinfo.org/glycan/G41137VS" denotes Gal
GlycanIUPAC_T58 338-341 "http://rdf.glycoinfo.org/glycan/G30521NA" denotes Gal
GlycanIUPAC_T59 466-469 "http://rdf.glycoinfo.org/glycan/G30521NA" denotes Gal
GlycanIUPAC_T60 1645-1648 "http://rdf.glycoinfo.org/glycan/G30521NA" denotes Gal
GlycanIUPAC_T61 338-341 "http://rdf.glycoinfo.org/glycan/G19388CD" denotes Gal
GlycanIUPAC_T62 466-469 "http://rdf.glycoinfo.org/glycan/G19388CD" denotes Gal
GlycanIUPAC_T63 1645-1648 "http://rdf.glycoinfo.org/glycan/G19388CD" denotes Gal
GlycanIUPAC_T64 338-341 "http://rdf.glycoinfo.org/glycan/G53151FU" denotes Gal
GlycanIUPAC_T65 466-469 "http://rdf.glycoinfo.org/glycan/G53151FU" denotes Gal
GlycanIUPAC_T66 1645-1648 "http://rdf.glycoinfo.org/glycan/G53151FU" denotes Gal
GlycanIUPAC_T67 338-341 "http://rdf.glycoinfo.org/glycan/G27105XC" denotes Gal
GlycanIUPAC_T68 466-469 "http://rdf.glycoinfo.org/glycan/G27105XC" denotes Gal
GlycanIUPAC_T69 1645-1648 "http://rdf.glycoinfo.org/glycan/G27105XC" denotes Gal
GlycanIUPAC_T70 338-341 "http://rdf.glycoinfo.org/glycan/G91210VM" denotes Gal
GlycanIUPAC_T71 466-469 "http://rdf.glycoinfo.org/glycan/G91210VM" denotes Gal
GlycanIUPAC_T72 1645-1648 "http://rdf.glycoinfo.org/glycan/G91210VM" denotes Gal
GlycanIUPAC_T73 338-341 "http://rdf.glycoinfo.org/glycan/G40841DE" denotes Gal
GlycanIUPAC_T74 466-469 "http://rdf.glycoinfo.org/glycan/G40841DE" denotes Gal
GlycanIUPAC_T75 1645-1648 "http://rdf.glycoinfo.org/glycan/G40841DE" denotes Gal
GlycanIUPAC_T76 338-341 "http://rdf.glycoinfo.org/glycan/G71241HP" denotes Gal
GlycanIUPAC_T77 466-469 "http://rdf.glycoinfo.org/glycan/G71241HP" denotes Gal
GlycanIUPAC_T78 1645-1648 "http://rdf.glycoinfo.org/glycan/G71241HP" denotes Gal
GlycanIUPAC_T79 338-341 "http://rdf.glycoinfo.org/glycan/G84636BJ" denotes Gal
GlycanIUPAC_T80 466-469 "http://rdf.glycoinfo.org/glycan/G84636BJ" denotes Gal
GlycanIUPAC_T81 1645-1648 "http://rdf.glycoinfo.org/glycan/G84636BJ" denotes Gal
GlycanIUPAC_T82 338-341 "http://rdf.glycoinfo.org/glycan/G47905LJ" denotes Gal
GlycanIUPAC_T83 466-469 "http://rdf.glycoinfo.org/glycan/G47905LJ" denotes Gal
GlycanIUPAC_T84 1645-1648 "http://rdf.glycoinfo.org/glycan/G47905LJ" denotes Gal
GlycanIUPAC_T85 338-341 "http://rdf.glycoinfo.org/glycan/G39340DV" denotes Gal
GlycanIUPAC_T86 466-469 "http://rdf.glycoinfo.org/glycan/G39340DV" denotes Gal
GlycanIUPAC_T87 1645-1648 "http://rdf.glycoinfo.org/glycan/G39340DV" denotes Gal
GlycanIUPAC_T88 338-341 "http://rdf.glycoinfo.org/glycan/G48801AQ" denotes Gal
GlycanIUPAC_T89 466-469 "http://rdf.glycoinfo.org/glycan/G48801AQ" denotes Gal
GlycanIUPAC_T90 1645-1648 "http://rdf.glycoinfo.org/glycan/G48801AQ" denotes Gal
GlycanIUPAC_T91 338-341 "http://rdf.glycoinfo.org/glycan/G14573NX" denotes Gal
GlycanIUPAC_T92 466-469 "http://rdf.glycoinfo.org/glycan/G14573NX" denotes Gal
GlycanIUPAC_T93 1645-1648 "http://rdf.glycoinfo.org/glycan/G14573NX" denotes Gal
GlycanIUPAC_T94 338-341 "http://rdf.glycoinfo.org/glycan/G56762TR" denotes Gal
GlycanIUPAC_T95 466-469 "http://rdf.glycoinfo.org/glycan/G56762TR" denotes Gal
GlycanIUPAC_T96 1645-1648 "http://rdf.glycoinfo.org/glycan/G56762TR" denotes Gal
GlycanIUPAC_T97 338-341 "http://rdf.glycoinfo.org/glycan/G20013XO" denotes Gal
GlycanIUPAC_T98 466-469 "http://rdf.glycoinfo.org/glycan/G20013XO" denotes Gal
GlycanIUPAC_T99 1645-1648 "http://rdf.glycoinfo.org/glycan/G20013XO" denotes Gal
GlycanIUPAC_T100 338-341 "http://rdf.glycoinfo.org/glycan/G39504DR" denotes Gal
GlycanIUPAC_T101 466-469 "http://rdf.glycoinfo.org/glycan/G39504DR" denotes Gal
GlycanIUPAC_T102 1645-1648 "http://rdf.glycoinfo.org/glycan/G39504DR" denotes Gal
GlycanIUPAC_T103 338-341 "http://rdf.glycoinfo.org/glycan/G35218RQ" denotes Gal
GlycanIUPAC_T104 466-469 "http://rdf.glycoinfo.org/glycan/G35218RQ" denotes Gal
GlycanIUPAC_T105 1645-1648 "http://rdf.glycoinfo.org/glycan/G35218RQ" denotes Gal
GlycanIUPAC_T106 338-341 "http://rdf.glycoinfo.org/glycan/G53048SH" denotes Gal
GlycanIUPAC_T107 466-469 "http://rdf.glycoinfo.org/glycan/G53048SH" denotes Gal
GlycanIUPAC_T108 1645-1648 "http://rdf.glycoinfo.org/glycan/G53048SH" denotes Gal
GlycanIUPAC_T109 338-341 "http://rdf.glycoinfo.org/glycan/G78418IX" denotes Gal
GlycanIUPAC_T110 466-469 "http://rdf.glycoinfo.org/glycan/G78418IX" denotes Gal
GlycanIUPAC_T111 1645-1648 "http://rdf.glycoinfo.org/glycan/G78418IX" denotes Gal
GlycanIUPAC_T112 338-341 "http://rdf.glycoinfo.org/glycan/G09780OD" denotes Gal
GlycanIUPAC_T113 466-469 "http://rdf.glycoinfo.org/glycan/G09780OD" denotes Gal
GlycanIUPAC_T114 1645-1648 "http://rdf.glycoinfo.org/glycan/G09780OD" denotes Gal
GlycanIUPAC_T115 338-341 "http://rdf.glycoinfo.org/glycan/G56359GL" denotes Gal
GlycanIUPAC_T116 466-469 "http://rdf.glycoinfo.org/glycan/G56359GL" denotes Gal
GlycanIUPAC_T117 1645-1648 "http://rdf.glycoinfo.org/glycan/G56359GL" denotes Gal
GlycanIUPAC_T118 338-341 "http://rdf.glycoinfo.org/glycan/G78941YC" denotes Gal
GlycanIUPAC_T119 466-469 "http://rdf.glycoinfo.org/glycan/G78941YC" denotes Gal
GlycanIUPAC_T120 1645-1648 "http://rdf.glycoinfo.org/glycan/G78941YC" denotes Gal
GlycanIUPAC_T121 338-341 "http://rdf.glycoinfo.org/glycan/G26829FC" denotes Gal
GlycanIUPAC_T122 466-469 "http://rdf.glycoinfo.org/glycan/G26829FC" denotes Gal
GlycanIUPAC_T123 1645-1648 "http://rdf.glycoinfo.org/glycan/G26829FC" denotes Gal
GlycanIUPAC_T124 338-341 "http://rdf.glycoinfo.org/glycan/G88538ZC" denotes Gal
GlycanIUPAC_T125 466-469 "http://rdf.glycoinfo.org/glycan/G88538ZC" denotes Gal
GlycanIUPAC_T126 1645-1648 "http://rdf.glycoinfo.org/glycan/G88538ZC" denotes Gal
GlycanIUPAC_T127 338-341 "http://rdf.glycoinfo.org/glycan/G46593ZR" denotes Gal
GlycanIUPAC_T128 466-469 "http://rdf.glycoinfo.org/glycan/G46593ZR" denotes Gal
GlycanIUPAC_T129 1645-1648 "http://rdf.glycoinfo.org/glycan/G46593ZR" denotes Gal
GlycanIUPAC_T130 338-341 "http://rdf.glycoinfo.org/glycan/G43523TH" denotes Gal
GlycanIUPAC_T131 466-469 "http://rdf.glycoinfo.org/glycan/G43523TH" denotes Gal
GlycanIUPAC_T132 1645-1648 "http://rdf.glycoinfo.org/glycan/G43523TH" denotes Gal
GlycanIUPAC_T133 338-341 "http://rdf.glycoinfo.org/glycan/G36445ON" denotes Gal
GlycanIUPAC_T134 466-469 "http://rdf.glycoinfo.org/glycan/G36445ON" denotes Gal
GlycanIUPAC_T135 1645-1648 "http://rdf.glycoinfo.org/glycan/G36445ON" denotes Gal
GlycanIUPAC_T136 338-341 "http://rdf.glycoinfo.org/glycan/G67363FK" denotes Gal
GlycanIUPAC_T137 466-469 "http://rdf.glycoinfo.org/glycan/G67363FK" denotes Gal
GlycanIUPAC_T138 1645-1648 "http://rdf.glycoinfo.org/glycan/G67363FK" denotes Gal
GlycanIUPAC_T139 338-341 "http://rdf.glycoinfo.org/glycan/G17562KT" denotes Gal
GlycanIUPAC_T140 466-469 "http://rdf.glycoinfo.org/glycan/G17562KT" denotes Gal
GlycanIUPAC_T141 1645-1648 "http://rdf.glycoinfo.org/glycan/G17562KT" denotes Gal
GlycanIUPAC_T142 338-341 "http://rdf.glycoinfo.org/glycan/G24774YJ" denotes Gal
GlycanIUPAC_T143 466-469 "http://rdf.glycoinfo.org/glycan/G24774YJ" denotes Gal
GlycanIUPAC_T144 1645-1648 "http://rdf.glycoinfo.org/glycan/G24774YJ" denotes Gal
GlycanIUPAC_T145 338-341 "http://rdf.glycoinfo.org/glycan/G32162UO" denotes Gal
GlycanIUPAC_T146 466-469 "http://rdf.glycoinfo.org/glycan/G32162UO" denotes Gal
GlycanIUPAC_T147 1645-1648 "http://rdf.glycoinfo.org/glycan/G32162UO" denotes Gal
GlycanIUPAC_T148 338-341 "http://rdf.glycoinfo.org/glycan/G89163RR" denotes Gal
GlycanIUPAC_T149 466-469 "http://rdf.glycoinfo.org/glycan/G89163RR" denotes Gal
GlycanIUPAC_T150 1645-1648 "http://rdf.glycoinfo.org/glycan/G89163RR" denotes Gal
GlycanIUPAC_T151 338-341 "http://rdf.glycoinfo.org/glycan/G99522DY" denotes Gal
GlycanIUPAC_T152 466-469 "http://rdf.glycoinfo.org/glycan/G99522DY" denotes Gal
GlycanIUPAC_T153 1645-1648 "http://rdf.glycoinfo.org/glycan/G99522DY" denotes Gal
GlycanIUPAC_T154 338-341 "http://rdf.glycoinfo.org/glycan/G59246IF" denotes Gal
GlycanIUPAC_T155 466-469 "http://rdf.glycoinfo.org/glycan/G59246IF" denotes Gal
GlycanIUPAC_T156 1645-1648 "http://rdf.glycoinfo.org/glycan/G59246IF" denotes Gal
GlycanIUPAC_T157 338-341 "http://rdf.glycoinfo.org/glycan/G95321NT" denotes Gal
GlycanIUPAC_T158 466-469 "http://rdf.glycoinfo.org/glycan/G95321NT" denotes Gal
GlycanIUPAC_T159 1645-1648 "http://rdf.glycoinfo.org/glycan/G95321NT" denotes Gal
GlycanIUPAC_T160 338-341 "http://rdf.glycoinfo.org/glycan/G17531ZI" denotes Gal
GlycanIUPAC_T161 466-469 "http://rdf.glycoinfo.org/glycan/G17531ZI" denotes Gal
GlycanIUPAC_T162 1645-1648 "http://rdf.glycoinfo.org/glycan/G17531ZI" denotes Gal
GlycanIUPAC_T163 338-341 "http://rdf.glycoinfo.org/glycan/G54322SU" denotes Gal
GlycanIUPAC_T164 466-469 "http://rdf.glycoinfo.org/glycan/G54322SU" denotes Gal
GlycanIUPAC_T165 1645-1648 "http://rdf.glycoinfo.org/glycan/G54322SU" denotes Gal
GlycanIUPAC_T166 338-341 "http://rdf.glycoinfo.org/glycan/G72010DO" denotes Gal
GlycanIUPAC_T167 466-469 "http://rdf.glycoinfo.org/glycan/G72010DO" denotes Gal
GlycanIUPAC_T168 1645-1648 "http://rdf.glycoinfo.org/glycan/G72010DO" denotes Gal
GlycanIUPAC_T169 338-341 "http://rdf.glycoinfo.org/glycan/G44269EP" denotes Gal
GlycanIUPAC_T170 466-469 "http://rdf.glycoinfo.org/glycan/G44269EP" denotes Gal
GlycanIUPAC_T171 1645-1648 "http://rdf.glycoinfo.org/glycan/G44269EP" denotes Gal
GlycanIUPAC_T172 338-341 "http://rdf.glycoinfo.org/glycan/G57335AD" denotes Gal
GlycanIUPAC_T173 466-469 "http://rdf.glycoinfo.org/glycan/G57335AD" denotes Gal
GlycanIUPAC_T174 1645-1648 "http://rdf.glycoinfo.org/glycan/G57335AD" denotes Gal
GlycanIUPAC_T175 338-341 "http://rdf.glycoinfo.org/glycan/G60837LL" denotes Gal
GlycanIUPAC_T176 466-469 "http://rdf.glycoinfo.org/glycan/G60837LL" denotes Gal
GlycanIUPAC_T177 1645-1648 "http://rdf.glycoinfo.org/glycan/G60837LL" denotes Gal
GlycanIUPAC_T178 338-341 "http://rdf.glycoinfo.org/glycan/G61929XX" denotes Gal
GlycanIUPAC_T179 466-469 "http://rdf.glycoinfo.org/glycan/G61929XX" denotes Gal
GlycanIUPAC_T180 1645-1648 "http://rdf.glycoinfo.org/glycan/G61929XX" denotes Gal
GlycanIUPAC_T181 338-341 "http://rdf.glycoinfo.org/glycan/G88747RA" denotes Gal
GlycanIUPAC_T182 466-469 "http://rdf.glycoinfo.org/glycan/G88747RA" denotes Gal
GlycanIUPAC_T183 1645-1648 "http://rdf.glycoinfo.org/glycan/G88747RA" denotes Gal
GlycanIUPAC_T184 338-341 "http://rdf.glycoinfo.org/glycan/G47955HA" denotes Gal
GlycanIUPAC_T185 466-469 "http://rdf.glycoinfo.org/glycan/G47955HA" denotes Gal
GlycanIUPAC_T186 1645-1648 "http://rdf.glycoinfo.org/glycan/G47955HA" denotes Gal
GlycanIUPAC_T187 338-341 "http://rdf.glycoinfo.org/glycan/G60982WS" denotes Gal
GlycanIUPAC_T188 466-469 "http://rdf.glycoinfo.org/glycan/G60982WS" denotes Gal
GlycanIUPAC_T189 1645-1648 "http://rdf.glycoinfo.org/glycan/G60982WS" denotes Gal
GlycanIUPAC_T190 338-341 "http://rdf.glycoinfo.org/glycan/G37035KG" denotes Gal
GlycanIUPAC_T191 466-469 "http://rdf.glycoinfo.org/glycan/G37035KG" denotes Gal
GlycanIUPAC_T192 1645-1648 "http://rdf.glycoinfo.org/glycan/G37035KG" denotes Gal
GlycanIUPAC_T193 338-341 "http://rdf.glycoinfo.org/glycan/G46297FI" denotes Gal
GlycanIUPAC_T194 466-469 "http://rdf.glycoinfo.org/glycan/G46297FI" denotes Gal
GlycanIUPAC_T195 1645-1648 "http://rdf.glycoinfo.org/glycan/G46297FI" denotes Gal
GlycanIUPAC_T196 338-341 "http://rdf.glycoinfo.org/glycan/G35475KI" denotes Gal
GlycanIUPAC_T197 466-469 "http://rdf.glycoinfo.org/glycan/G35475KI" denotes Gal
GlycanIUPAC_T198 1645-1648 "http://rdf.glycoinfo.org/glycan/G35475KI" denotes Gal
GlycanIUPAC_T199 338-341 "http://rdf.glycoinfo.org/glycan/G29771JN" denotes Gal
GlycanIUPAC_T200 466-469 "http://rdf.glycoinfo.org/glycan/G29771JN" denotes Gal
GlycanIUPAC_T201 1645-1648 "http://rdf.glycoinfo.org/glycan/G29771JN" denotes Gal
GlycanIUPAC_T202 338-341 "http://rdf.glycoinfo.org/glycan/G61285YR" denotes Gal
GlycanIUPAC_T203 466-469 "http://rdf.glycoinfo.org/glycan/G61285YR" denotes Gal
GlycanIUPAC_T204 1645-1648 "http://rdf.glycoinfo.org/glycan/G61285YR" denotes Gal
GlycanIUPAC_T205 338-341 "http://rdf.glycoinfo.org/glycan/G54785MW" denotes Gal
GlycanIUPAC_T206 466-469 "http://rdf.glycoinfo.org/glycan/G54785MW" denotes Gal
GlycanIUPAC_T207 1645-1648 "http://rdf.glycoinfo.org/glycan/G54785MW" denotes Gal
GlycanIUPAC_T208 338-341 "http://rdf.glycoinfo.org/glycan/G53039GT" denotes Gal
GlycanIUPAC_T209 466-469 "http://rdf.glycoinfo.org/glycan/G53039GT" denotes Gal
GlycanIUPAC_T210 1645-1648 "http://rdf.glycoinfo.org/glycan/G53039GT" denotes Gal
GlycanIUPAC_T211 338-341 "http://rdf.glycoinfo.org/glycan/G00601HK" denotes Gal
GlycanIUPAC_T212 466-469 "http://rdf.glycoinfo.org/glycan/G00601HK" denotes Gal
GlycanIUPAC_T213 1645-1648 "http://rdf.glycoinfo.org/glycan/G00601HK" denotes Gal
GlycanIUPAC_T214 338-341 "http://rdf.glycoinfo.org/glycan/G10485IJ" denotes Gal
GlycanIUPAC_T215 466-469 "http://rdf.glycoinfo.org/glycan/G10485IJ" denotes Gal
GlycanIUPAC_T216 1645-1648 "http://rdf.glycoinfo.org/glycan/G10485IJ" denotes Gal
GlycanIUPAC_T217 338-341 "http://rdf.glycoinfo.org/glycan/G16393IB" denotes Gal
GlycanIUPAC_T218 466-469 "http://rdf.glycoinfo.org/glycan/G16393IB" denotes Gal
GlycanIUPAC_T219 1645-1648 "http://rdf.glycoinfo.org/glycan/G16393IB" denotes Gal
GlycanIUPAC_T220 338-341 "http://rdf.glycoinfo.org/glycan/G98436FZ" denotes Gal
GlycanIUPAC_T221 466-469 "http://rdf.glycoinfo.org/glycan/G98436FZ" denotes Gal
GlycanIUPAC_T222 1645-1648 "http://rdf.glycoinfo.org/glycan/G98436FZ" denotes Gal
GlycanIUPAC_T223 338-341 "http://rdf.glycoinfo.org/glycan/G18825IA" denotes Gal
GlycanIUPAC_T224 466-469 "http://rdf.glycoinfo.org/glycan/G18825IA" denotes Gal
GlycanIUPAC_T225 1645-1648 "http://rdf.glycoinfo.org/glycan/G18825IA" denotes Gal
GlycanIUPAC_T226 338-341 "http://rdf.glycoinfo.org/glycan/G61281HQ" denotes Gal
GlycanIUPAC_T227 466-469 "http://rdf.glycoinfo.org/glycan/G61281HQ" denotes Gal
GlycanIUPAC_T228 1645-1648 "http://rdf.glycoinfo.org/glycan/G61281HQ" denotes Gal
GlycanIUPAC_T229 338-341 "http://rdf.glycoinfo.org/glycan/G07798TI" denotes Gal
GlycanIUPAC_T230 466-469 "http://rdf.glycoinfo.org/glycan/G07798TI" denotes Gal
GlycanIUPAC_T231 1645-1648 "http://rdf.glycoinfo.org/glycan/G07798TI" denotes Gal
GlycanIUPAC_T232 338-341 "http://rdf.glycoinfo.org/glycan/G55921QA" denotes Gal
GlycanIUPAC_T233 466-469 "http://rdf.glycoinfo.org/glycan/G55921QA" denotes Gal
GlycanIUPAC_T234 1645-1648 "http://rdf.glycoinfo.org/glycan/G55921QA" denotes Gal
GlycanIUPAC_T235 338-341 "http://rdf.glycoinfo.org/glycan/G99066DL" denotes Gal
GlycanIUPAC_T236 466-469 "http://rdf.glycoinfo.org/glycan/G99066DL" denotes Gal
GlycanIUPAC_T237 1645-1648 "http://rdf.glycoinfo.org/glycan/G99066DL" denotes Gal
GlycanIUPAC_T238 338-341 "http://rdf.glycoinfo.org/glycan/G33451PQ" denotes Gal
GlycanIUPAC_T239 466-469 "http://rdf.glycoinfo.org/glycan/G33451PQ" denotes Gal
GlycanIUPAC_T240 1645-1648 "http://rdf.glycoinfo.org/glycan/G33451PQ" denotes Gal
GlycanIUPAC_T241 338-341 "http://rdf.glycoinfo.org/glycan/G02111XU" denotes Gal
GlycanIUPAC_T242 466-469 "http://rdf.glycoinfo.org/glycan/G02111XU" denotes Gal
GlycanIUPAC_T243 1645-1648 "http://rdf.glycoinfo.org/glycan/G02111XU" denotes Gal
GlycanIUPAC_T244 338-341 "http://rdf.glycoinfo.org/glycan/G85193OM" denotes Gal
GlycanIUPAC_T245 466-469 "http://rdf.glycoinfo.org/glycan/G85193OM" denotes Gal
GlycanIUPAC_T246 1645-1648 "http://rdf.glycoinfo.org/glycan/G85193OM" denotes Gal
GlycanIUPAC_T247 338-341 "http://rdf.glycoinfo.org/glycan/G89174YQ" denotes Gal
GlycanIUPAC_T248 466-469 "http://rdf.glycoinfo.org/glycan/G89174YQ" denotes Gal
GlycanIUPAC_T249 1645-1648 "http://rdf.glycoinfo.org/glycan/G89174YQ" denotes Gal
GlycanIUPAC_T250 338-341 "http://rdf.glycoinfo.org/glycan/G28802LE" denotes Gal
GlycanIUPAC_T251 466-469 "http://rdf.glycoinfo.org/glycan/G28802LE" denotes Gal
GlycanIUPAC_T252 1645-1648 "http://rdf.glycoinfo.org/glycan/G28802LE" denotes Gal
GlycanIUPAC_T253 338-341 "http://rdf.glycoinfo.org/glycan/G56061JK" denotes Gal
GlycanIUPAC_T254 466-469 "http://rdf.glycoinfo.org/glycan/G56061JK" denotes Gal
GlycanIUPAC_T255 1645-1648 "http://rdf.glycoinfo.org/glycan/G56061JK" denotes Gal
GlycanIUPAC_T256 338-341 "http://rdf.glycoinfo.org/glycan/G68941BC" denotes Gal
GlycanIUPAC_T257 466-469 "http://rdf.glycoinfo.org/glycan/G68941BC" denotes Gal
GlycanIUPAC_T258 1645-1648 "http://rdf.glycoinfo.org/glycan/G68941BC" denotes Gal
GlycanIUPAC_T259 338-341 "http://rdf.glycoinfo.org/glycan/G55436FC" denotes Gal
GlycanIUPAC_T260 466-469 "http://rdf.glycoinfo.org/glycan/G55436FC" denotes Gal
GlycanIUPAC_T261 1645-1648 "http://rdf.glycoinfo.org/glycan/G55436FC" denotes Gal
GlycanIUPAC_T262 338-341 "http://rdf.glycoinfo.org/glycan/G24002PU" denotes Gal
GlycanIUPAC_T263 466-469 "http://rdf.glycoinfo.org/glycan/G24002PU" denotes Gal
GlycanIUPAC_T264 1645-1648 "http://rdf.glycoinfo.org/glycan/G24002PU" denotes Gal
GlycanIUPAC_T265 338-341 "http://rdf.glycoinfo.org/glycan/G61387SV" denotes Gal
GlycanIUPAC_T266 466-469 "http://rdf.glycoinfo.org/glycan/G61387SV" denotes Gal
GlycanIUPAC_T267 1645-1648 "http://rdf.glycoinfo.org/glycan/G61387SV" denotes Gal
GlycanIUPAC_T268 338-341 "http://rdf.glycoinfo.org/glycan/G31834HW" denotes Gal
GlycanIUPAC_T269 466-469 "http://rdf.glycoinfo.org/glycan/G31834HW" denotes Gal
GlycanIUPAC_T270 1645-1648 "http://rdf.glycoinfo.org/glycan/G31834HW" denotes Gal
GlycanIUPAC_T271 338-341 "http://rdf.glycoinfo.org/glycan/G35324RT" denotes Gal
GlycanIUPAC_T272 466-469 "http://rdf.glycoinfo.org/glycan/G35324RT" denotes Gal
GlycanIUPAC_T273 1645-1648 "http://rdf.glycoinfo.org/glycan/G35324RT" denotes Gal
GlycanIUPAC_T274 338-341 "http://rdf.glycoinfo.org/glycan/G34803QO" denotes Gal
GlycanIUPAC_T275 466-469 "http://rdf.glycoinfo.org/glycan/G34803QO" denotes Gal
GlycanIUPAC_T276 1645-1648 "http://rdf.glycoinfo.org/glycan/G34803QO" denotes Gal
GlycanIUPAC_T277 338-341 "http://rdf.glycoinfo.org/glycan/G92898FF" denotes Gal
GlycanIUPAC_T278 466-469 "http://rdf.glycoinfo.org/glycan/G92898FF" denotes Gal
GlycanIUPAC_T279 1645-1648 "http://rdf.glycoinfo.org/glycan/G92898FF" denotes Gal
GlycanIUPAC_T280 338-341 "http://rdf.glycoinfo.org/glycan/G01318VX" denotes Gal
GlycanIUPAC_T281 466-469 "http://rdf.glycoinfo.org/glycan/G01318VX" denotes Gal
GlycanIUPAC_T282 1645-1648 "http://rdf.glycoinfo.org/glycan/G01318VX" denotes Gal
GlycanIUPAC_T283 338-341 "http://rdf.glycoinfo.org/glycan/G83200MX" denotes Gal
GlycanIUPAC_T284 466-469 "http://rdf.glycoinfo.org/glycan/G83200MX" denotes Gal
GlycanIUPAC_T285 1645-1648 "http://rdf.glycoinfo.org/glycan/G83200MX" denotes Gal
GlycanIUPAC_T286 338-341 "http://rdf.glycoinfo.org/glycan/G56286UC" denotes Gal
GlycanIUPAC_T287 466-469 "http://rdf.glycoinfo.org/glycan/G56286UC" denotes Gal
GlycanIUPAC_T288 1645-1648 "http://rdf.glycoinfo.org/glycan/G56286UC" denotes Gal
GlycanIUPAC_T289 338-341 "http://rdf.glycoinfo.org/glycan/G07304QA" denotes Gal
GlycanIUPAC_T290 466-469 "http://rdf.glycoinfo.org/glycan/G07304QA" denotes Gal
GlycanIUPAC_T291 1645-1648 "http://rdf.glycoinfo.org/glycan/G07304QA" denotes Gal
GlycanIUPAC_T292 338-341 "http://rdf.glycoinfo.org/glycan/G06868OU" denotes Gal
GlycanIUPAC_T293 466-469 "http://rdf.glycoinfo.org/glycan/G06868OU" denotes Gal
GlycanIUPAC_T294 1645-1648 "http://rdf.glycoinfo.org/glycan/G06868OU" denotes Gal
GlycanIUPAC_T295 338-341 "http://rdf.glycoinfo.org/glycan/G12647BS" denotes Gal
GlycanIUPAC_T296 466-469 "http://rdf.glycoinfo.org/glycan/G12647BS" denotes Gal
GlycanIUPAC_T297 1645-1648 "http://rdf.glycoinfo.org/glycan/G12647BS" denotes Gal
GlycanIUPAC_T298 338-341 "http://rdf.glycoinfo.org/glycan/G51841DF" denotes Gal
GlycanIUPAC_T299 466-469 "http://rdf.glycoinfo.org/glycan/G51841DF" denotes Gal
GlycanIUPAC_T300 1645-1648 "http://rdf.glycoinfo.org/glycan/G51841DF" denotes Gal
GlycanIUPAC_T301 338-341 "http://rdf.glycoinfo.org/glycan/G32122AJ" denotes Gal
GlycanIUPAC_T302 466-469 "http://rdf.glycoinfo.org/glycan/G32122AJ" denotes Gal
GlycanIUPAC_T303 1645-1648 "http://rdf.glycoinfo.org/glycan/G32122AJ" denotes Gal
GlycanIUPAC_T304 338-341 "http://rdf.glycoinfo.org/glycan/G41125MN" denotes Gal
GlycanIUPAC_T305 466-469 "http://rdf.glycoinfo.org/glycan/G41125MN" denotes Gal
GlycanIUPAC_T306 1645-1648 "http://rdf.glycoinfo.org/glycan/G41125MN" denotes Gal
GlycanIUPAC_T307 338-341 "http://rdf.glycoinfo.org/glycan/G16093XS" denotes Gal
GlycanIUPAC_T308 466-469 "http://rdf.glycoinfo.org/glycan/G16093XS" denotes Gal
GlycanIUPAC_T309 1645-1648 "http://rdf.glycoinfo.org/glycan/G16093XS" denotes Gal
GlycanIUPAC_T310 338-341 "http://rdf.glycoinfo.org/glycan/G62425IX" denotes Gal
GlycanIUPAC_T311 466-469 "http://rdf.glycoinfo.org/glycan/G62425IX" denotes Gal
GlycanIUPAC_T312 1645-1648 "http://rdf.glycoinfo.org/glycan/G62425IX" denotes Gal
GlycanIUPAC_T313 338-341 "http://rdf.glycoinfo.org/glycan/G15673TO" denotes Gal
GlycanIUPAC_T314 466-469 "http://rdf.glycoinfo.org/glycan/G15673TO" denotes Gal
GlycanIUPAC_T315 1645-1648 "http://rdf.glycoinfo.org/glycan/G15673TO" denotes Gal
GlycanIUPAC_T316 338-341 "http://rdf.glycoinfo.org/glycan/G32857IK" denotes Gal
GlycanIUPAC_T317 466-469 "http://rdf.glycoinfo.org/glycan/G32857IK" denotes Gal
GlycanIUPAC_T318 1645-1648 "http://rdf.glycoinfo.org/glycan/G32857IK" denotes Gal
GlycanIUPAC_T319 338-341 "http://rdf.glycoinfo.org/glycan/G60047CJ" denotes Gal
GlycanIUPAC_T320 466-469 "http://rdf.glycoinfo.org/glycan/G60047CJ" denotes Gal
GlycanIUPAC_T321 1645-1648 "http://rdf.glycoinfo.org/glycan/G60047CJ" denotes Gal
GlycanIUPAC_T322 338-341 "http://rdf.glycoinfo.org/glycan/G55718ZB" denotes Gal
GlycanIUPAC_T323 466-469 "http://rdf.glycoinfo.org/glycan/G55718ZB" denotes Gal
GlycanIUPAC_T324 1645-1648 "http://rdf.glycoinfo.org/glycan/G55718ZB" denotes Gal
GlycanIUPAC_T325 338-341 "http://rdf.glycoinfo.org/glycan/G88355ZE" denotes Gal
GlycanIUPAC_T326 466-469 "http://rdf.glycoinfo.org/glycan/G88355ZE" denotes Gal
GlycanIUPAC_T327 1645-1648 "http://rdf.glycoinfo.org/glycan/G88355ZE" denotes Gal
GlycanIUPAC_T328 338-341 "http://rdf.glycoinfo.org/glycan/G11283PA" denotes Gal
GlycanIUPAC_T329 466-469 "http://rdf.glycoinfo.org/glycan/G11283PA" denotes Gal
GlycanIUPAC_T330 1645-1648 "http://rdf.glycoinfo.org/glycan/G11283PA" denotes Gal
GlycanIUPAC_T331 338-341 "http://rdf.glycoinfo.org/glycan/G71737IZ" denotes Gal
GlycanIUPAC_T332 466-469 "http://rdf.glycoinfo.org/glycan/G71737IZ" denotes Gal
GlycanIUPAC_T333 1645-1648 "http://rdf.glycoinfo.org/glycan/G71737IZ" denotes Gal
GlycanIUPAC_T334 338-341 "http://rdf.glycoinfo.org/glycan/G60912WZ" denotes Gal
GlycanIUPAC_T335 466-469 "http://rdf.glycoinfo.org/glycan/G60912WZ" denotes Gal
GlycanIUPAC_T336 1645-1648 "http://rdf.glycoinfo.org/glycan/G60912WZ" denotes Gal
GlycanIUPAC_T337 338-341 "http://rdf.glycoinfo.org/glycan/G99655SO" denotes Gal
GlycanIUPAC_T338 466-469 "http://rdf.glycoinfo.org/glycan/G99655SO" denotes Gal
GlycanIUPAC_T339 1645-1648 "http://rdf.glycoinfo.org/glycan/G99655SO" denotes Gal
GlycanIUPAC_T340 338-341 "http://rdf.glycoinfo.org/glycan/G10300TW" denotes Gal
GlycanIUPAC_T341 466-469 "http://rdf.glycoinfo.org/glycan/G10300TW" denotes Gal
GlycanIUPAC_T342 1645-1648 "http://rdf.glycoinfo.org/glycan/G10300TW" denotes Gal
GlycanIUPAC_T343 338-341 "http://rdf.glycoinfo.org/glycan/G89509FL" denotes Gal
GlycanIUPAC_T344 466-469 "http://rdf.glycoinfo.org/glycan/G89509FL" denotes Gal
GlycanIUPAC_T345 1645-1648 "http://rdf.glycoinfo.org/glycan/G89509FL" denotes Gal
GlycanIUPAC_T346 338-341 "http://rdf.glycoinfo.org/glycan/G31465TH" denotes Gal
GlycanIUPAC_T347 466-469 "http://rdf.glycoinfo.org/glycan/G31465TH" denotes Gal
GlycanIUPAC_T348 1645-1648 "http://rdf.glycoinfo.org/glycan/G31465TH" denotes Gal
GlycanIUPAC_T349 338-341 "http://rdf.glycoinfo.org/glycan/G94101LU" denotes Gal
GlycanIUPAC_T350 466-469 "http://rdf.glycoinfo.org/glycan/G94101LU" denotes Gal
GlycanIUPAC_T351 1645-1648 "http://rdf.glycoinfo.org/glycan/G94101LU" denotes Gal
GlycanIUPAC_T352 338-341 "http://rdf.glycoinfo.org/glycan/G38610BB" denotes Gal
GlycanIUPAC_T353 466-469 "http://rdf.glycoinfo.org/glycan/G38610BB" denotes Gal
GlycanIUPAC_T354 1645-1648 "http://rdf.glycoinfo.org/glycan/G38610BB" denotes Gal
GlycanIUPAC_T355 338-341 "http://rdf.glycoinfo.org/glycan/G85893UF" denotes Gal
GlycanIUPAC_T356 466-469 "http://rdf.glycoinfo.org/glycan/G85893UF" denotes Gal
GlycanIUPAC_T357 1645-1648 "http://rdf.glycoinfo.org/glycan/G85893UF" denotes Gal
GlycanIUPAC_T358 1518-1524 "http://rdf.glycoinfo.org/glycan/G59665TO" denotes sugars
GlycanIUPAC_T359 1534-1539 "http://rdf.glycoinfo.org/glycan/G59665TO" denotes sugar
GlycanIUPAC_T360 1518-1524 "http://rdf.glycoinfo.org/glycan/G32915EI" denotes sugars
GlycanIUPAC_T361 1534-1539 "http://rdf.glycoinfo.org/glycan/G32915EI" denotes sugar
GlycanIUPAC_T362 1518-1524 "http://rdf.glycoinfo.org/glycan/G60625TS" denotes sugars
GlycanIUPAC_T363 1534-1539 "http://rdf.glycoinfo.org/glycan/G60625TS" denotes sugar

Glycan-GlyCosmos

Id Subject Object Predicate Lexical cue image
T1 1248-1254 Glycan denotes LacNAc https://api.glycosmos.org/wurcs2image/latest/png/binary/G66213AR
T2 1332-1338 Glycan denotes LacNAc https://api.glycosmos.org/wurcs2image/latest/png/binary/G66213AR
T3 1421-1427 Glycan denotes LacNAc https://api.glycosmos.org/wurcs2image/latest/png/binary/G66213AR

sentences

Id Subject Object Predicate Lexical cue
TextSentencer_T1 0-132 Sentence denotes Characterization of the substrate specificity of alpha1,3galactosyltransferase utilizing modified N-acetyllactosamine disaccharides.
TextSentencer_T2 133-342 Sentence denotes alpha1,3galactosyltransferase (alpha1,3GalT) catalyzes the synthesis of a range of glycoconjugates containing the Galalpha1,3Gal epitope which is recognized by the naturally occurring human antibody, anti-Gal.
TextSentencer_T3 343-524 Sentence denotes This enzyme may be a useful synthetic tool to produce a range of compounds to further investigate the binding site of anti-Gal and other proteins with a Galalpha1,3Gal binding site.
TextSentencer_T4 525-627 Sentence denotes Thus, the enzyme has been probed with a series of type 2 disaccharide-C8(Galbeta1-4GlcNAc-C8) analogs.
TextSentencer_T5 628-804 Sentence denotes The enzyme tolerated acceptors with modifications at C2 and C3 of the N-acetylglucosamine residue, producing a family of compounds with a nonreducing alpha1,3 linked galactose.
TextSentencer_T6 805-876 Sentence denotes Compounds that did not serve as acceptors were evaluated as inhibitors.
TextSentencer_T7 877-1038 Sentence denotes Interestingly, the type 1 disaccharide-C8, Galbeta1-3GlcNAc-C8, was a good inhibitor of the enzyme (Ki = 270 microM vs. Km = 190 microM for Galbeta1-4GlcNAc-C8).
TextSentencer_T8 1039-1431 Sentence denotes A potential photoprobe, based on a modified type 2 disaccharide (octyl 3-amino-3-deoxy-3-N-(2-diazo-3, 3, 3-trifluoropropionyl-beta-D-galactopyranosyl-(1, 4)-2-acetamindo-2-deoxy-beta-D-glycopyranoside, (DTFP-LacNAc-C8)), was evaluated as an inhibitor of alpha1,3GalT. alpha1,3GalT bound DTFP-LacNAc-C8 with an affinity (Ki = 300 microM) similar to that displayed by the enzyme for LacNAc-C8.
TextSentencer_T9 1432-1547 Sentence denotes Additional studies were done to determine the enzyme's ability to transfer a range of sugars from UDP-sugar donors.
TextSentencer_T10 1548-1649 Sentence denotes The results of these experiments demonstrated that alpha1,3GalT has a strict specificity for UDP-Gal.
TextSentencer_T11 1650-1824 Sentence denotes Finally, inactivation studies with various amino acid modifiers were done to obtain information on the importance of different types of amino acids for alpha1,3GalT activity.
T1 0-132 Sentence denotes Characterization of the substrate specificity of alpha1,3galactosyltransferase utilizing modified N-acetyllactosamine disaccharides.
T2 133-524 Sentence denotes alpha1,3galactosyltransferase (alpha1,3GalT) catalyzes the synthesis of a range of glycoconjugates containing the Galalpha1,3Gal epitope which is recognized by the naturally occurring human antibody, anti-Gal. This enzyme may be a useful synthetic tool to produce a range of compounds to further investigate the binding site of anti-Gal and other proteins with a Galalpha1,3Gal binding site.
T3 525-627 Sentence denotes Thus, the enzyme has been probed with a series of type 2 disaccharide-C8(Galbeta1-4GlcNAc-C8) analogs.
T4 628-804 Sentence denotes The enzyme tolerated acceptors with modifications at C2 and C3 of the N-acetylglucosamine residue, producing a family of compounds with a nonreducing alpha1,3 linked galactose.
T5 805-876 Sentence denotes Compounds that did not serve as acceptors were evaluated as inhibitors.
T6 877-1038 Sentence denotes Interestingly, the type 1 disaccharide-C8, Galbeta1-3GlcNAc-C8, was a good inhibitor of the enzyme (Ki = 270 microM vs. Km = 190 microM for Galbeta1-4GlcNAc-C8).
T7 1039-1431 Sentence denotes A potential photoprobe, based on a modified type 2 disaccharide (octyl 3-amino-3-deoxy-3-N-(2-diazo-3, 3, 3-trifluoropropionyl-beta-D-galactopyranosyl-(1, 4)-2-acetamindo-2-deoxy-beta-D-glycopyranoside, (DTFP-LacNAc-C8)), was evaluated as an inhibitor of alpha1,3GalT. alpha1,3GalT bound DTFP-LacNAc-C8 with an affinity (Ki = 300 microM) similar to that displayed by the enzyme for LacNAc-C8.
T8 1432-1547 Sentence denotes Additional studies were done to determine the enzyme's ability to transfer a range of sugars from UDP-sugar donors.
T9 1548-1824 Sentence denotes The results of these experiments demonstrated that alpha1,3GalT has a strict specificity for UDP-Gal. Finally, inactivation studies with various amino acid modifiers were done to obtain information on the importance of different types of amino acids for alpha1,3GalT activity.
T1 0-132 Sentence denotes Characterization of the substrate specificity of alpha1,3galactosyltransferase utilizing modified N-acetyllactosamine disaccharides.
T2 133-342 Sentence denotes alpha1,3galactosyltransferase (alpha1,3GalT) catalyzes the synthesis of a range of glycoconjugates containing the Galalpha1,3Gal epitope which is recognized by the naturally occurring human antibody, anti-Gal.
T3 343-524 Sentence denotes This enzyme may be a useful synthetic tool to produce a range of compounds to further investigate the binding site of anti-Gal and other proteins with a Galalpha1,3Gal binding site.
T4 525-627 Sentence denotes Thus, the enzyme has been probed with a series of type 2 disaccharide-C8(Galbeta1-4GlcNAc-C8) analogs.
T5 628-804 Sentence denotes The enzyme tolerated acceptors with modifications at C2 and C3 of the N-acetylglucosamine residue, producing a family of compounds with a nonreducing alpha1,3 linked galactose.
T6 805-876 Sentence denotes Compounds that did not serve as acceptors were evaluated as inhibitors.
T7 877-1038 Sentence denotes Interestingly, the type 1 disaccharide-C8, Galbeta1-3GlcNAc-C8, was a good inhibitor of the enzyme (Ki = 270 microM vs. Km = 190 microM for Galbeta1-4GlcNAc-C8).
T8 1039-1431 Sentence denotes A potential photoprobe, based on a modified type 2 disaccharide (octyl 3-amino-3-deoxy-3-N-(2-diazo-3, 3, 3-trifluoropropionyl-beta-D-galactopyranosyl-(1, 4)-2-acetamindo-2-deoxy-beta-D-glycopyranoside, (DTFP-LacNAc-C8)), was evaluated as an inhibitor of alpha1,3GalT. alpha1,3GalT bound DTFP-LacNAc-C8 with an affinity (Ki = 300 microM) similar to that displayed by the enzyme for LacNAc-C8.
T9 1432-1547 Sentence denotes Additional studies were done to determine the enzyme's ability to transfer a range of sugars from UDP-sugar donors.
T10 1548-1649 Sentence denotes The results of these experiments demonstrated that alpha1,3GalT has a strict specificity for UDP-Gal.
T11 1650-1824 Sentence denotes Finally, inactivation studies with various amino acid modifiers were done to obtain information on the importance of different types of amino acids for alpha1,3GalT activity.

GlyCosmos15-Sentences

Id Subject Object Predicate Lexical cue
T1 0-132 Sentence denotes Characterization of the substrate specificity of alpha1,3galactosyltransferase utilizing modified N-acetyllactosamine disaccharides.
T2 133-524 Sentence denotes alpha1,3galactosyltransferase (alpha1,3GalT) catalyzes the synthesis of a range of glycoconjugates containing the Galalpha1,3Gal epitope which is recognized by the naturally occurring human antibody, anti-Gal. This enzyme may be a useful synthetic tool to produce a range of compounds to further investigate the binding site of anti-Gal and other proteins with a Galalpha1,3Gal binding site.
T3 525-627 Sentence denotes Thus, the enzyme has been probed with a series of type 2 disaccharide-C8(Galbeta1-4GlcNAc-C8) analogs.
T4 628-804 Sentence denotes The enzyme tolerated acceptors with modifications at C2 and C3 of the N-acetylglucosamine residue, producing a family of compounds with a nonreducing alpha1,3 linked galactose.
T5 805-876 Sentence denotes Compounds that did not serve as acceptors were evaluated as inhibitors.
T6 877-1038 Sentence denotes Interestingly, the type 1 disaccharide-C8, Galbeta1-3GlcNAc-C8, was a good inhibitor of the enzyme (Ki = 270 microM vs. Km = 190 microM for Galbeta1-4GlcNAc-C8).
T7 1039-1431 Sentence denotes A potential photoprobe, based on a modified type 2 disaccharide (octyl 3-amino-3-deoxy-3-N-(2-diazo-3, 3, 3-trifluoropropionyl-beta-D-galactopyranosyl-(1, 4)-2-acetamindo-2-deoxy-beta-D-glycopyranoside, (DTFP-LacNAc-C8)), was evaluated as an inhibitor of alpha1,3GalT. alpha1,3GalT bound DTFP-LacNAc-C8 with an affinity (Ki = 300 microM) similar to that displayed by the enzyme for LacNAc-C8.
T8 1432-1547 Sentence denotes Additional studies were done to determine the enzyme's ability to transfer a range of sugars from UDP-sugar donors.
T9 1548-1824 Sentence denotes The results of these experiments demonstrated that alpha1,3GalT has a strict specificity for UDP-Gal. Finally, inactivation studies with various amino acid modifiers were done to obtain information on the importance of different types of amino acids for alpha1,3GalT activity.

GlyCosmos15-NCBITAXON

Id Subject Object Predicate Lexical cue db_id
T1 317-322 OrganismTaxon denotes human 9606

GlyCosmos15-Glycan

Id Subject Object Predicate Lexical cue image
T1 1248-1254 Glycan denotes LacNAc https://api.glycosmos.org/wurcs2image/latest/png/binary/G66213AR
T2 1332-1338 Glycan denotes LacNAc https://api.glycosmos.org/wurcs2image/latest/png/binary/G66213AR
T3 1421-1427 Glycan denotes LacNAc https://api.glycosmos.org/wurcs2image/latest/png/binary/G66213AR

NCBITAXON

Id Subject Object Predicate Lexical cue db_id
T1 317-322 OrganismTaxon denotes human 9606